288 related articles for article (PubMed ID: 14962083)
1. Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage.
Ohnemus U; Unalan M; Handjiski B; Paus R
J Invest Dermatol; 2004 Jan; 122(1):7-13. PubMed ID: 14962083
[TBL] [Abstract][Full Text] [Related]
2. A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist.
Peters EM; Foitzik K; Paus R; Ray S; Holick MF
J Invest Dermatol; 2001 Aug; 117(2):173-8. PubMed ID: 11511291
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia.
Paik SH; Yoon JS; Ryu HH; Lee JY; Shin CY; Min KH; Jo SJ; Kim KH; Kwon O
Exp Dermatol; 2013 Jul; 22(7):496-9. PubMed ID: 23800066
[TBL] [Abstract][Full Text] [Related]
4. Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice.
Paus R; Schilli MB; Handjiski B; Menrad A; Henz BM; Plonka P
Cancer Res; 1996 Oct; 56(19):4438-43. PubMed ID: 8813138
[TBL] [Abstract][Full Text] [Related]
5. Modulation of chemotherapy-induced human hair follicle damage by 17-beta estradiol and prednisolone: potential stimulators of normal hair regrowth by "dystrophic catagen" promotion?
Bodó E; van Beek N; Naumann V; Ohnemus U; Brzoska T; Abels C; Paus R
J Invest Dermatol; 2009 Feb; 129(2):506-9. PubMed ID: 18704109
[No Abstract] [Full Text] [Related]
6. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
Maurer M; Handjiski B; Paus R
Am J Pathol; 1997 Apr; 150(4):1433-41. PubMed ID: 9094998
[TBL] [Abstract][Full Text] [Related]
7. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.
Paus R; Handjiski B; Eichmüller S; Czarnetzki BM
Am J Pathol; 1994 Apr; 144(4):719-34. PubMed ID: 8160773
[TBL] [Abstract][Full Text] [Related]
8. Human placenta induces hair regrowth in chemotherapy-induced alopecia via inhibition of apoptotic factors and proliferation of hair follicles.
Kim MH; Kim K; Lee H; Yang WM
BMC Complement Med Ther; 2020 Jul; 20(1):230. PubMed ID: 32689985
[TBL] [Abstract][Full Text] [Related]
9. A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice.
Hendrix S; Handjiski B; Peters EM; Paus R
J Invest Dermatol; 2005 Jul; 125(1):42-51. PubMed ID: 15982301
[TBL] [Abstract][Full Text] [Related]
10. Hair cycle control by estrogens: catagen induction via estrogen receptor (ER)-alpha is checked by ER beta signaling.
Ohnemus U; Uenalan M; Conrad F; Handjiski B; Mecklenburg L; Nakamura M; Inzunza J; Gustafsson JA; Paus R
Endocrinology; 2005 Mar; 146(3):1214-25. PubMed ID: 15591132
[TBL] [Abstract][Full Text] [Related]
11. Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs.
Schilli MB; Paus R; Menrad A
J Invest Dermatol; 1998 Oct; 111(4):598-604. PubMed ID: 9764839
[TBL] [Abstract][Full Text] [Related]
12. Effect of adenovirus-mediated expression of Sonic hedgehog gene on hair regrowth in mice with chemotherapy-induced alopecia.
Sato N; Leopold PL; Crystal RG
J Natl Cancer Inst; 2001 Dec; 93(24):1858-64. PubMed ID: 11752010
[TBL] [Abstract][Full Text] [Related]
13. Zinc as an ambivalent but potent modulator of murine hair growth in vivo- preliminary observations.
Plonka PM; Handjiski B; Popik M; Michalczyk D; Paus R
Exp Dermatol; 2005 Nov; 14(11):844-53. PubMed ID: 16232307
[TBL] [Abstract][Full Text] [Related]
14. Parathyroid hormone linked to a collagen binding domain promotes hair growth in a mouse model of chemotherapy-induced alopecia in a dose-dependent manner.
Katikaneni R; Ponnapakkam T; Seymour A; Sakon J; Gensure R
Anticancer Drugs; 2014 Aug; 25(7):819-25. PubMed ID: 24710191
[TBL] [Abstract][Full Text] [Related]
15. Development of a Model for Chemotherapy-Induced Alopecia: Profiling of Histological Changes in Human Hair Follicles after Chemotherapy.
Yoon JS; Choi M; Shin CY; Paik SH; Kim KH; Kwon O
J Invest Dermatol; 2016 Mar; 136(3):584-92. PubMed ID: 26774950
[TBL] [Abstract][Full Text] [Related]
16. Topical application of cyclosporin A induces rapid-remodeling of damaged anagen hair follicles produced in cyclophosphamide administered mice.
Shirai A; Tsunoda H; Tamaoki T; Kamiya T
J Dermatol Sci; 2001 Sep; 27(1):7-13. PubMed ID: 11457638
[TBL] [Abstract][Full Text] [Related]
17. Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice.
Chen SS; Zhang Y; Lu QL; Lin Z; Zhao Y
Environ Toxicol Pharmacol; 2016 Sep; 46():270-276. PubMed ID: 27522546
[TBL] [Abstract][Full Text] [Related]
18. Topical fulvestrant solution has no effect on male and postmenopausal female androgenetic alopecia: results from two randomized, proof-of-concept studies.
Gassmueller J; Hoffmann R; Webster A
Br J Dermatol; 2008 Jan; 158(1):109-15. PubMed ID: 17986309
[TBL] [Abstract][Full Text] [Related]
19. Caveolin-1 is expressed on multipotent cells of hair follicles and might be involved in their resistance to chemotherapy.
Selleri S; Arnaboldi F; Palazzo M; Hussein U; Balsari A; Rumio C
Br J Dermatol; 2005 Sep; 153(3):506-13. PubMed ID: 16120134
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of topical tofacitinib in promoting hair growth in non-scarring alopecia: possible mechanism via VEGF induction.
Meephansan J; Thummakriengkrai J; Ponnikorn S; Yingmema W; Deenonpoe R; Suchonwanit P
Arch Dermatol Res; 2017 Nov; 309(9):729-738. PubMed ID: 28884378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
